Friday, October 16, 2020 8:55:13 PM
You can call the CEO anytime or contact him via linkedln. Check the last two press release his number is there.
Paul M Michaels - Chief Executive Officer - Connectyx Technologies
For the past two decades, established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field Expertise in financing, risk management, global business development, mergers and acquisitions and cross-border pharmaceutical licensing. Completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and…
Paul M Michaels - Chief Executive Officer - Connectyx Technologies
For the past two decades, established lasting relationships with key business leaders and stakeholders in Japan and the U.S., particularly in the Life Sciences field Expertise in financing, risk management, global business development, mergers and acquisitions and cross-border pharmaceutical licensing. Completed transactions that influenced companies such as Celgene Corporation, Sumitomo Pharmaceuticals, Nobelpharma Co., Ltd, Teva Pharmaceuticals, ICOS, Neurocrine, Cell Therapeutics and…
Recent CUBTD News
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
